Skip to main content
. 2023 Feb 14;13(2):325. doi: 10.3390/jpm13020325

Table 1.

Baseline characteristics of randomized participants.

Treatment Groups
Characteristic All Placebo Low-Dose
(0.01% Atropine)
Loading Dose
(0.1% to 0.01% Atropine)
N (%) 97 32 (33.0) 32 (33.0) 33 (34.0)
Site, N (%)
Copenhagen 43 (44.3) 14 (32.6) 14 (32.6) 15 (34.9)
Vejle 41 (42.3) 13 (31.7) 14 (34.1) 14 (34.1)
Aarhus 13 (13.4) 5 (38.5) 4 (30.8) 4 (30.8)
Female/Male (%) 55/42 (57/43) 18/14 (56/44) 18/14 (56/44) 19/14 (58/42)
Age, mean (SD), years 9.4 (1.7) 9.2 (1.6) 9.4 (1.9) 9.5 (1.5)
Race, N (%)
White 82 (84.5) 29 (90.6) 25 (78.1) 28 (84.8)
Mixed race 9 (9.3) 3 (9.4) 3 (9.4) 3 (9.1)
Middle East 3 (3.1)
Asian 2 (2.1)
Black or African American 1 (1.0)
AL, mean (SD), mm 24.48 (0.84) 24.41 (0.90) 24.56 (0.78) 24.48 (0.86)
SE, mean (SD), D −3.02 (1.27) −3.07 (1.04) −2.97 (1.13) −3.0 (1.59)
CCT, mean (SD), µm 546.8 (30.3) 546.0 (35.1) 546.4 (25.7) 547.8 (30.3)
ACD, mean (SD), mm 3.31 (0.24) 3.32 (0.27) 3.33 (0.26) 3.28 (0.19)
Photopic pupil size, mean (SD), mm 2.68 (0.33) 2.64 (0.31) 2.60 (0.30) 2.80 (0.36)
Mesopic pupil size, mean (SD), mm 4.24 (0.74) 4.11 (0.74) 4.17 (0.58) 4.42 (0.84)
Distance BCVA, mean (SD), logMAR −0.09 (0.06) −0.09 (0.06) −0.09 (0.05) −0.08 (0.07)
Near BCVA, mean (SD), logMAR −0.04 (0.09) −0.03 (0.09) −0.05 (0.09) −0.04 (0.09)
Accom. amplitude, mean (SD), D 14.5 (4.0) 14.1 (4.4) 14.3 (3.9) 15.1 (3.6)
ChT, mean (SD), µm 247.9 (66.2) 244.0 (65.1) 259.8 (66.7) 240.2 (67.2)
IOP, mean (SD), mmHg 16.1 (2.7) 16.1 (2.5) 15.8 (3.1) 16.5 (2.7)

Abbreviations: Accom. = accommodation; ACD = anterior chamber depth; AL = axial length; BCVA = best-corrected visual acuity; CCT = central corneal thickness; ChT = choroidal thickness; D = diopters; IOP = intraocular pressure; logMAR = logarithm of the minimum angle of resolution; N = number of participants; SE = spherical equivalent; SD = standard deviation; ― = not specified due to risk of unmasking.